Economy

Record Demand at NewMed Energy: NIS 2.4 Billion in Institutional Phase of Bond Offering

Bonds, illustration
Bonds, illustration | Photo: Shutterstock

NewMed Energy announced the successful completion of the institutional phase of an offering of a new bond series (Series B).

Government bonds
Government bonds | Photo: Shutterstock

During the institutional tender, enormous demand was recorded from the market's leading institutional investors, totaling about NIS 2.4 billion. Of the total demand, the partnership decided to accept orders totaling about NIS 1.751 billion.

Terms of the Series and Fundraising Objectives

The new bond series is expected to be listed for trading on the Tel Aviv Stock Exchange (TASE). It will bear annual interest of up to 4.54%, without indexation or collateral. The series has an average duration of about 5 years, with repayments in installments spread from 2027 through 2034. The partnership intends to obtain approval from rating agency Midroog for an A1 rating for the full amount of the series.

One-hundred- and two-hundred-shekel banknotes
Cash | Photo: Shutterstock

The offering proceeds are intended to diversify the partnership's financing sources and support the implementation of its ambitious work plans for the coming years. Key objectives include developing Phase B of the Leviathan reservoir, advancing the development of the Aphrodite reservoir, which is approaching a final investment decision, and repaying existing debt. Completion of the entire fundraising is subject to publication of the public tender and receipt of the required approvals.

Fundraising Leadership and Advisers

The fundraising was led by the partnership's management, headed by CEO Niv Sarna and Deputy CEO and CFO Tzachi Havusha.

Leviathan platform
Leviathan platform | Photo: Marc Israel Sellem, Flash90, Shutterstock

The offering was conducted in cooperation with underwriters Barak Leumi Underwriting, Discount Underwriting and Leader Underwriters. The offering process was accompanied by the law firm Agmon with Tulchinsky and financial adviser Shay Adler.

Partnership Management: "A Clear Expression of Confidence in Financial Strength"

NewMed Energy CEO Niv Sarna said the results of the institutional tender indicate a clear expression of confidence by institutional investors in the partnership and its business strategy.

According to Sarna, the offering proceeds, combined with the strong cash flow from the Leviathan reservoir, will enable the partnership to continue advancing its development plans for the coming years, including developing Phase B of Leviathan and the Aphrodite reservoir, while providing returns to investors and maintaining an appropriate leverage level.

Niv Sarna, CEO of NewMed Energy Credit | Inbal Marmari | Photo: Inbal Marmari

Deputy CEO and CFO Tzachi Havusha added that the successful fundraising and high demand reflect the capital market's confidence in the partnership's financial strength and execution capabilities. Havusha stressed that the fundraising strengthens financial flexibility and creates an efficient and balanced capital and debt structure, which will enable the partnership to generate value for investors over time.

Key takeaways

  • NewMed Energy completed the institutional phase of a new bond series offering and saw demand of about NIS 2.4 billion.
  • The partnership accepted orders totaling about NIS 1.751 billion in the institutional tender.
  • The new bond series is expected to be listed on the Tel Aviv Stock Exchange and will bear annual interest of up to 4.54%, without indexation or collateral.
  • NewMed Energy plans to use the proceeds to diversify financing sources, support development of Phase B of Leviathan and the Aphrodite reservoir, and repay existing debt.
  • The company said the fundraising reflects confidence in its financial strength and will help maintain an appropriate leverage level.

Questions and answers

How much demand did NewMed Energy get in the institutional phase of its bond offering?
The institutional tender drew about NIS 2.4 billion in demand from leading institutional investors. NewMed Energy decided to accept orders totaling about NIS 1.751 billion.
What are the main terms of the new bond series?
The series is expected to be listed on the Tel Aviv Stock Exchange and will carry annual interest of up to 4.54%. It is unsecured, not linked to an index, and has an average duration of about 5 years.
What will NewMed Energy use the bond proceeds for?
The proceeds are intended to diversify financing sources and support work plans for the coming years. The article says the goals include developing Phase B of Leviathan, advancing Aphrodite, and repaying existing debt.

Share this story

About the writer

Shay Nogai

Writes for TV10, Israel’s economic channel. This story was translated from the original Hebrew.

More stories by Shay Nogai

More for you